中文产业新闻评分38Chinese source
emugrobart肥胖适应症II期开发终止，Chugai拟重启SMA开发
2期临床，减肥抗体新药：终止开发
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
2期临床，减肥抗体新药：终止开发
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.